Search

everythinglearnresearchcommunity

for

Search:↓

Engineered skin tissue is a promising tool for safer cosmetic testing.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Nanocarriers show promise for improving skin drug delivery in treating skin conditions.

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Zinc pyrithione needs targeted delivery to the scalp for effective dandruff treatment.

Common skin conditions can greatly affect a person's mental health and social life.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Beetroot extract nanogel may help treat hair loss caused by testosterone.

Exosomes could be a promising way to help repair skin and treat skin disorders.

Plant adaptogens may help treat skin diseases and improve skin health, but more research is needed to fully understand how they work.

Noni fruit extract, specifically the FEA-3 sub-fraction, can increase hair growth and reduce baldness in male rabbits, potentially acting like common hair loss treatments.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The TRPV3 ion channel is important for skin and hair health and could be a target for treating skin conditions.

Cutaneous lupus can cause permanent hair loss by damaging hair follicles.

ING5 is crucial for stem cell maintenance and preventing certain cancers.

The conclusion is that a team of skin doctors and psychiatrists is needed to better treat patients with mind-skin disorders.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

AGA affects many, progresses differently, and early treatment is crucial.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Angiopoietin-1 helps hair cells survive and grow, making it a potential treatment for hair loss.